<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">usfd</journal-id><journal-title-group><journal-title xml:lang="ru">Ультразвуковая и функциональная диагностика</journal-title><trans-title-group xml:lang="en"><trans-title>Ultrasound &amp; Functional Diagnostics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0771</issn><issn pub-type="epub">2408-9494</issn><publisher><publisher-name>RDS-Media Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24835/1607-0771-278</article-id><article-id custom-type="elpub" pub-id-type="custom">usfd-278</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Ультразвуковая диагностика в акушерстве и гинекологии</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Obstetrics and Gynecology Ultrasound</subject></subj-group></article-categories><title-group><article-title>Ультразвуковая диагностика серозных опухолей яичников: возможности, сложности, перспективы (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Ultrasound of serous ovarian tumors: possibilities, difficulties, prospects (review article)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5565-2511</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чекалова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chekalova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чекалова Марина Альбертовна – профессор, доктор мед. наук, профессор кафедры рентгенологии и ультразвуковой диагностики ФГБУ “Федеральный научный клинический центр специализированных видов медицинской помощи и медицинских технологий” ФМБА России, Москва. <ext-link xlink:href="https://orcid.org/0000-0002-5565-2511" ext-link-type="uri">https://orcid.org/0000-0002-5565-2511</ext-link>E-mail: ch2me@yandex.ru </p></bio><bio xml:lang="en"><p>Marina A. Chekalova – M.D., Doct. of Sci. (Med.), Professor, Professor of the Department of Radiology and Ultrasound Diagnostics, Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies, Federal Medical-Biological Agency (FMBA of Russia), Moscow.<ext-link xlink:href="https://orcid.org/0000-0002-5565-2511" ext-link-type="uri">https://orcid.org/0000-0002-5565-2511</ext-link>E-mail: ch2me@yandex.ru</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9660-923X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карселадзе</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Karseladze</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карселадзе Аполлон Иродионович – доктор мед. наук, профессор, советник генерального директора ФГБУ “Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова” Минздрава России, Москва.<ext-link xlink:href="https://orcid.org/0000-0001-9660-923" ext-link-type="uri">https://orcid.org/0000-0001-9660-923</ext-link>E-mail: vacutuchuni@mail.ru </p></bio><bio xml:lang="en"><p>Apollon I. Karseladze – M.D., Doct. of Sci. (Med.),  Professor, Advisor to the Director General, National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow. <ext-link xlink:href="https://orcid.org/0000-0001-9660-923" ext-link-type="uri">https://orcid.org/0000-0001-9660-923X</ext-link>E-mail: vacutuchuni@mail.ru</p></bio><email xlink:type="simple">vacutuchuni@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0031-7406</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдова</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Davydova</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Давыдова Ирина Юрьевна – доктор мед. наук, ведущий научный сотрудник отдела онкохирургии органов таза ГБУЗ “Московский клинический научный центр им. А.С. Логинова” ДЗ города Москвы, Москва.<ext-link xlink:href="https://orcid.org/0000-0003-0031-7406" ext-link-type="uri">https://orcid.org/0000-0003-0031-7406</ext-link>E-mail: i.davydova@mknc.ru </p></bio><bio xml:lang="en"><p>Irina Yu. Davydova – M.D., Doct. of Sci. (Med.),  Leading Researcher of the Department of Pelvic Organ Oncosurgery, Moscow Clinical Scientific Center named after A.S. Loginov of Moscow Healthcare Department, Moscow.<ext-link xlink:href="https://orcid.org/0000-0003-0031-7406" ext-link-type="uri">https://orcid.org/0000-0003-0031-7406</ext-link></p></bio><email xlink:type="simple">i.davydova@mknc.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8295-768X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буланов</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulanov</surname><given-names>M. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Буланов Михаил Николаевич – доктор мед. наук, заведующий отделением ультразвуковой диагностики ГБУЗ ВО “Областная клиническая больница”, Владимир; профессор кафедры внутренних болезней Института медицинского образования ФГБОУ ВО “Новгородский государственный университет имени Ярослава Мудрого”, Великий Новгород. https://orcid.org/0000-0001-8295-768X</p></bio><bio xml:lang="en"><p>Mikhail N. Bulanov – M.D., Doct. of Sci. (Med.), Head of Ultrasound Diagnostics Department, Regional Clinical Hospital, Vladimir; Professor, Division of Internal Medicine, Institute of Medical Education, Yaroslav-the-Wise Novgorod State University, Veliky Novgorod. https://orcid.org/0000-0001-8295-768X</p></bio><email xlink:type="simple">doctorbulanov@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0934-7011</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кряжева</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kryazheva</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кряжева Варвара Сергеевна – канд. мед. наук, врач ультразвуковой диагностики Центра амбулаторной онкологической помощи ГБУЗ “Московский многопрофильный клинический центр «Коммунарка»” ДЗ города Москвы, Москва.<ext-link xlink:href="https://orcid.org/0000-0003-0934-7011" ext-link-type="uri">https://orcid.org/0000-0003-0934-7011</ext-link>E-mail: salvaje2005@yandex.ru</p></bio><bio xml:lang="en"><p>Varvara S. Kryazheva – M.D., Cand. of Sci. (Med.), Doctor of ultrasound diagnostics, Center for Outpatient Oncological Care, Moscow Clinical Center “Kommunarka” of Moscow Healthcare Department, Moscow.<ext-link xlink:href="https://orcid.org/0000-0003-0934-7011" ext-link-type="uri">https://orcid.org/0000-0003-0934-7011</ext-link>E-mail: salvaje2005@yandex.ru</p></bio><email xlink:type="simple">salvaje2005@yandex.ru</email><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ “Федеральный научный клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства” Российской Федерации</institution></aff><aff xml:lang="en"><institution>Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies, Federal Medical-Biological Agency (FMBA of Russia)</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ “Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова” Минздрава России</institution></aff><aff xml:lang="en"><institution>Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov of the Ministry of Healthcare of the Russian Federation</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБУЗ “Московский клинический научный центр им. А.С. Логинова” ДЗ города Москвы</institution></aff><aff xml:lang="en"><institution>Moscow Clinical Scientific Center named after A.S. Loginov of Moscow Healthcare Department</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ГБУЗ Владимирской области “Областная клиническая больница”; ФГБОУ ВПО “Новгородский государственный университет имени Ярослава Мудрого”</institution></aff><aff xml:lang="en"><institution>Vladimir Regional Clinical Hospital; Yaroslav-the-Wise Novgorod State University</institution></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ГБУЗ “Московский многопрофильный клинический центр «Коммунарка»” ДЗ города Москвы</institution></aff><aff xml:lang="en"><institution>Moscow Clinical Center “Kommunarka” of Moscow Healthcare Department</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>05</day><month>02</month><year>2025</year></pub-date><volume>31</volume><issue>1</issue><fpage>47</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чекалова М.А., Карселадзе А.И., Давыдова И.Ю., Буланов М.Н., Кряжева В.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Чекалова М.А., Карселадзе А.И., Давыдова И.Ю., Буланов М.Н., Кряжева В.С.</copyright-holder><copyright-holder xml:lang="en">Chekalova M.A., Karseladze A.I., Davydova I.Y., Bulanov M.N., Kryazheva V.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://usfd.rdsmedia.ru/jour/article/view/278">https://usfd.rdsmedia.ru/jour/article/view/278</self-uri><abstract><p>Несмотря на то что многочисленные попытки исследователей решить проблему скрининга рака яичников с помощью трансвагинальной эхографии не увенчались успехом, тем не менее ее использование в диагностике опухоли яичников вполне обоснованно и целесообразно. Проанализированы современные отечественные и зарубежные данные, касающиеся вопросов дифференциальной диагностики между серозной пограничной опухолью и low grade серозной карциномой яичников. Ультразвуковое исследование является наиболее часто используемым диагностическим тестом для диагностики опухолей яичников. Ультразвуковое исследование с использованием современных ультразвуковых технологий, проведенное опытным специалистом, позволяет избежать ненужных или неэффективных операций. Результаты визуализации, характерные для пограничных серозных новообразований и опухолей низкой степени злокачественности, важны для своевременной правильной дифференциальной диагностики, результатом которой является выбор адекватного объема хирургического лечения этой категории пациенток. Улучшение диагностической визуализации рака яичников открывает перспективы для повышения эффективности лечения и вместе с тем изучения возможностей ранней диагностики серозных пограничных опухолей яичников и серозных карцином низкой степени злокачественности.</p></abstract><trans-abstract xml:lang="en"><p>In spite of numerous unsuccessful attempts by researchers to solve the problems of ovarian cancer screening with transvaginal ultrasound, its use in the ovarian cancer diagnosis is quite reasonable and appropriate. Modern domestic and foreign data on the issues of serous borderline tumors and low-grade serous ovarian carcinomas differentiation are analyzed. Ultrasound is the most commonly used modality for the diagnosis of ovarian tumors. Ultrasound, using modern ultrasound technologies, performed by an experienced specialist, allows avoiding unnecessary or ineffective surgery. The imaging features typical for serous borderline tumors and tumors of low-grade malignancy are important for timely and correct differential diagnosis, which results in the selection of an adequate volume of surgery for these patients. Improved imaging of ovarian cancer opens up prospects for increasing the treatment effectiveness and evaluation of possibilities of early diagnosis of serous borderline ovarian tumors and low-grade serous carcinomas.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак яичников</kwd><kwd>пограничные опухоли яичников</kwd><kwd>ультразвуковая диагностика</kwd><kwd>серозные опухоли яичников</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ovarian cancer</kwd><kwd>borderline ovarian tumors</kwd><kwd>ultrasound</kwd><kwd>serous ovarian tumors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Longacre T.A., Wells M., Kurman M.L. et al. Serous tumors. In: WHO Classification of Tumours of Female Reproductive Organs. IARC Press: Lyon, France, 2014: 15–24.</mixed-citation><mixed-citation xml:lang="en">Longacre T.A., Wells M., Kurman M.L. et al. Serous tumors. In: WHO Classification of Tumours of Female Reproductive Organs. IARC Press: Lyon, France, 2014: 15–24.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Folsom S.M., Berger J., Soong T.R., Rangaswamy B. Comprehensive Review of Serous Tumors of Tubo-Ovarian Origin: Clinical Behavior, Pathological Correlation, Current Molecular Updates, and Imaging Manifestations. Curr. Probl. Diagn. Radiol. 2023; 52 (5): 425–438. http://doi.org/10.1067/j.cpradiol.2023.05.010</mixed-citation><mixed-citation xml:lang="en">Folsom S.M., Berger J., Soong T.R., Rangaswamy B. Comprehensive Review of Serous Tumors of Tubo-Ovarian Origin: Clinical Behavior, Pathological Correlation, Current Molecular Updates, and Imaging Manifestations. Curr. Probl. Diagn. Radiol. 2023; 52 (5): 425–438. http://doi.org/10.1067/j.cpradiol.2023.05.010</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuo K., Machida H., Grubbs B.H. et al. Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study. Gynecol. Oncol. 2020; 157 (1): 21–28. http://doi.org/10.1016/j.ygyno.2019.08.030</mixed-citation><mixed-citation xml:lang="en">Matsuo K., Machida H., Grubbs B.H. et al. Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study. Gynecol. Oncol. 2020; 157 (1): 21–28. http://doi.org/10.1016/j.ygyno.2019.08.030</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao F., Zhang L., Yang S. et al. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors. J. Ovarian Res. 2022; 15 (1): 13. http://doi.org/10.1186/s13048-021-00920-y</mixed-citation><mixed-citation xml:lang="en">Xiao F., Zhang L., Yang S. et al. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors. J. Ovarian Res. 2022; 15 (1): 13. http://doi.org/10.1186/s13048-021-00920-y</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nougaret S., Lakhman Y., Molinari N. et al. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. Am. J. Roentgenol. 2018; 210 (4): 918–926. http://doi.org/10.2214/AJR.17.18254</mixed-citation><mixed-citation xml:lang="en">Nougaret S., Lakhman Y., Molinari N. et al. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. Am. J. Roentgenol. 2018; 210 (4): 918–926. http://doi.org/10.2214/AJR.17.18254</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Du Bois A., Trillsch F., Mahner S. et al. Management of borderline ovarian tumors. Ann. Oncol. 2016; 27 (Suppl. 1): i20–i22.</mixed-citation><mixed-citation xml:lang="en">Du Bois A., Trillsch F., Mahner S. et al. Management of borderline ovarian tumors. Ann. Oncol. 2016; 27 (Suppl. 1): i20–i22.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kurman R.J., Сarcanqiu M.L., Herrington C.S., Young R.H. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: IARS, 2014.</mixed-citation><mixed-citation xml:lang="en">Kurman R.J., Сarcanqiu M.L., Herrington C.S., Young R.H. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: IARS, 2014.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">WHO Classification of Tumours: 2020. Female genital Tumours. 5th ed. Lyon.</mixed-citation><mixed-citation xml:lang="en">WHO Classification of Tumours: 2020. Female genital Tumours. 5th ed. Lyon.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vang R., Hannibal C.G., Junge J. et al. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases. Am. J. Surg. Pathol. 2017; 41 (6): 725–737. http://doi.org/10.1097/PAS.0000000000000824</mixed-citation><mixed-citation xml:lang="en">Vang R., Hannibal C.G., Junge J. et al. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases. Am. J. Surg. Pathol. 2017; 41 (6): 725–737. http://doi.org/10.1097/PAS.0000000000000824</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bell K.A., Smith Sehdev A.E., Kurman R.J. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am. J. Surg. Pathol. 2001; 25 (4): 419–432. http://doi.org/10.1097/00000478-200104000-00001</mixed-citation><mixed-citation xml:lang="en">Bell K.A., Smith Sehdev A.E., Kurman R.J. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am. J. Surg. Pathol. 2001; 25 (4): 419–432. http://doi.org/10.1097/00000478-200104000-00001</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">May T., Virtanen C., Sharma M. et al. Low malignant potential tumors with micropapillary featuresare molecularly similar to low-grade serous carcinoma of the ovary. Gynecol. Oncol. 2010; 117 (1): 9–17. http://doi.org/10.1016/j.ygyno.2010.01.006</mixed-citation><mixed-citation xml:lang="en">May T., Virtanen C., Sharma M. et al. Low malignant potential tumors with micropapillary featuresare molecularly similar to low-grade serous carcinoma of the ovary. Gynecol. Oncol. 2010; 117 (1): 9–17. http://doi.org/10.1016/j.ygyno.2010.01.006</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Amante S., Santos F., Cunha T.M. Low-grade serous epithelial ovarian cancer: a comprehensive review and update for radiologists. Insights. Imaging. 2021; 12: 60. https://doi.org/10.1186/s13244-021-01004-7</mixed-citation><mixed-citation xml:lang="en">Amante S., Santos F., Cunha T.M. Low-grade serous epithelial ovarian cancer: a comprehensive review and update for radiologists. Insights. Imaging. 2021; 12: 60. https://doi.org/10.1186/s13244-021-01004-7</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lalwani N., Shanbhogue A.K., Vikram R. Current update on borderline ovarian neoplasms. Am. J. Roentgenol. 2010; 194 (2): 330–336. http://doi.org/10.2214/AJR.09.3936</mixed-citation><mixed-citation xml:lang="en">Lalwani N., Shanbhogue A.K., Vikram R. Current update on borderline ovarian neoplasms. Am. J. Roentgenol. 2010; 194 (2): 330–336. http://doi.org/10.2214/AJR.09.3936</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ayhan A., Akarin R., Develioglu O. et al. Borderline epithelial ovarian tumors. Aust. N. Z. J. Obstet Gynecol. 1991; 31 (2): 174–176. http://doi.org/10.1111/j.1479-828x.1991.tb01812.x</mixed-citation><mixed-citation xml:lang="en">Ayhan A., Akarin R., Develioglu O. et al. Borderline epithelial ovarian tumors. Aust. N. Z. J. Obstet Gynecol. 1991; 31 (2): 174–176. http://doi.org/10.1111/j.1479-828x.1991.tb01812.x</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Seidman J.D., Horkayne-Szakaly I., Haiba M. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int. J. Gynecol. Pathol. 2004; 23: 41–44. http://doi.org/10.1097/01.pgp.0000101080.35393.16</mixed-citation><mixed-citation xml:lang="en">Seidman J.D., Horkayne-Szakaly I., Haiba M. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int. J. Gynecol. Pathol. 2004; 23: 41–44. http://doi.org/10.1097/01.pgp.0000101080.35393.16</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Moro F., Baima Poma C., Zannoni G.F., Testa A.C. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors. Ultrasound Obstet. Gynecol. 2017; 50 (6): 788–799. http://doi.org/10.1002/uog.17414</mixed-citation><mixed-citation xml:lang="en">Moro F., Baima Poma C., Zannoni G.F., Testa A.C. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors. Ultrasound Obstet. Gynecol. 2017; 50 (6): 788–799. http://doi.org/10.1002/uog.17414</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Давыдова И.Ю., Чекалова М.А., Карселадзе А.И. и др. Серозные пограничные опухоли яичников: современные возможности ультразвуковой диагностики в мониторинге течения болезни после органосохраняющих операций. Современная онкология. 2021; 23 (1): 106–111. http://doi.org/10.26442/18151434.2021.1.20057</mixed-citation><mixed-citation xml:lang="en">Davydova I.Yu., Chekalova M.A., Karseladze A.I. et al. Serous borderline ovarian tumors: modern possibilities of ultrasound diagnostics in monitoring the course of the disease after organ-preserving operations. Modern Oncology. 2021; 23 (1): 106–111. http://doi.org/10.26442/18151434.2021.1.20057</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Чекалова М.А., Давыдова И.Ю., Карселадзе А.И., Мещерякова Л.А., Кузнецов В.Н., Черкасов Е.Ю. Серозные пограничные опухоли яичников: особенности ультразвукового изображения. Опухоли женской репродуктивной системы. 2020; 16 (2): 55–62. https://doi.org/10.17650/1994-4098-2020-16-2-55-61</mixed-citation><mixed-citation xml:lang="en">Chekalova M.A., Davydova I.Yu., Karseladze A.I. et al. Serous borderline ovarian tumors: features of ultrasound imaging. Tumors of the Female Reproductive System. 2020; 16 (2): 55–62. https://doi.org/10.17650/1994-4098-2020-16-2-55-61</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Di Legge A., Pollastri P., Mancari R. et al. Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essay. Ultrasound Obstet. Gynecol. 2017; 50 (5): 648–656. http://doi.org/10.1002/uog.17392</mixed-citation><mixed-citation xml:lang="en">Di Legge A., Pollastri P., Mancari R. et al. Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essay. Ultrasound Obstet. Gynecol. 2017; 50 (5): 648–656. http://doi.org/10.1002/uog.17392</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Exacoustos C., Romanini M.E., Rinaldo D. et al. Preoperative sonographic features of borderline ovarian tumors. Ultrasound Obstet. Gynecol. 2005; 25 (1): 50–59. http://doi.org/10.1002/uog.1823</mixed-citation><mixed-citation xml:lang="en">Exacoustos C., Romanini M.E., Rinaldo D. et al. Preoperative sonographic features of borderline ovarian tumors. Ultrasound Obstet. Gynecol. 2005; 25 (1): 50–59. http://doi.org/10.1002/uog.1823</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Van Calster B., Van Hoorde K., Valentin L. et al.; International Ovarian Tumour Analysis Group. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ. 2014; 349:g5920. http://doi.org/10.1136/bmj.g5920</mixed-citation><mixed-citation xml:lang="en">Van Calster B., Van Hoorde K., Valentin L. et al.; International Ovarian Tumour Analysis Group. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ. 2014; 349:g5920. http://doi.org/10.1136/bmj.g5920</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Di Legge A., Testa A.C., Ameye L. et al. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses. Ultrasound Obstet. Gynecol. 2012; 40: 345–354. http://doi.org/10.1002/uog.11167</mixed-citation><mixed-citation xml:lang="en">Di Legge A., Testa A.C., Ameye L. et al. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses. Ultrasound Obstet. Gynecol. 2012; 40: 345–354. http://doi.org/10.1002/uog.11167</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrazzi E., Lissoni A.A., Dordoni D. et al. Differentiation of small adnexal masses based on morphologic characteristics of transvaginal sonographic imaging: a multicenter study. J. Ultrasound Med. 2005; 24: 1467–1473. http://doi.org/10.7863/jum.2005.24.11.1467</mixed-citation><mixed-citation xml:lang="en">Ferrazzi E., Lissoni A.A., Dordoni D. et al. Differentiation of small adnexal masses based on morphologic characteristics of transvaginal sonographic imaging: a multicenter study. J. Ultrasound Med. 2005; 24: 1467–1473. http://doi.org/10.7863/jum.2005.24.11.1467</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hu R., Xiang H., Mu Y. et al. Combination of 2- and 3-dimensional contrast-enhanced transvaginal sonography for diagnosis of small adnexal masses. J. Ultrasound Med. 2014; 33: 1889–1899. http://doi.org/10.7863/ultra.33.11.1889</mixed-citation><mixed-citation xml:lang="en">Hu R., Xiang H., Mu Y. et al. Combination of 2- and 3-dimensional contrast-enhanced transvaginal sonography for diagnosis of small adnexal masses. J. Ultrasound Med. 2014; 33: 1889–1899. http://doi.org/10.7863/ultra.33.11.1889</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Timmerman D., Testa A.C, Bourne T. et al. International Ovarian Tumor Analysis Group. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J. Clin. Oncol. 2005; 23: 8794–8801. http://doi.org/10.1200/JCO.2005.01.7632</mixed-citation><mixed-citation xml:lang="en">Timmerman D., Testa A.C, Bourne T. et al. International Ovarian Tumor Analysis Group. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J. Clin. Oncol. 2005; 23: 8794–8801. http://doi.org/10.1200/JCO.2005.01.7632</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Valentin L., Ameye L., Testa A. et al. Ultrasound characteristics of different types of adnexal malignancies. Gynecol. Oncol. 2006; 102: 41–48. http://doi.org/10.1016/j.ygyno.2005.11.015</mixed-citation><mixed-citation xml:lang="en">Valentin L., Ameye L., Testa A. et al. Ultrasound characteristics of different types of adnexal malignancies. Gynecol. Oncol. 2006; 102: 41–48. http://doi.org/10.1016/j.ygyno.2005.11.015</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Goldstein S.R., Timor-Tritsch I.E., Monteagudo A. et al. Cystadenofibromas: Can transvaginal ultrasound appearance reduce some surgical interventions? J. Clin. Ultrasound. 2015; 43: 393–396. http://doi.org/10.1002/jcu.22241</mixed-citation><mixed-citation xml:lang="en">Goldstein S.R., Timor-Tritsch I.E., Monteagudo A. et al. Cystadenofibromas: Can transvaginal ultrasound appearance reduce some surgical interventions? J. Clin. Ultrasound. 2015; 43: 393–396. http://doi.org/10.1002/jcu.22241</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Kurman R.J., Carcangiu M.L., Herrington C.S., Young R.H. (eds). WHO classification of tumours of female reproductive organs (4th edn). International Agency for Research on Cancer (IARC): Lyon, 2014.</mixed-citation><mixed-citation xml:lang="en">Kurman R.J., Carcangiu M.L., Herrington C.S., Young R.H. (eds). WHO classification of tumours of female reproductive organs (4th edn). International Agency for Research on Cancer (IARC): Lyon, 2014.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hillaby K., Aslam N., Salim R. et al. The value of detection of normal ovarian tissue (the ‘ovarian crescent sign’) in the differential diagnosis of adnexal masses. Ultrasound Obstet. Gynecol. 2004; 23: 63–67. http://doi.org/10.1002/uog.946</mixed-citation><mixed-citation xml:lang="en">Hillaby K., Aslam N., Salim R. et al. The value of detection of normal ovarian tissue (the ‘ovarian crescent sign’) in the differential diagnosis of adnexal masses. Ultrasound Obstet. Gynecol. 2004; 23: 63–67. http://doi.org/10.1002/uog.946</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Van Holsbeke C., Van Belle V., Leone F.D. et al. Prospective external validation of the ‘ovarian crescent sign’ as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology. Ultrasound Obstet. Gynecol. 2010; 36: 81–87. http://doi.org/10.1002/uog.7625</mixed-citation><mixed-citation xml:lang="en">Van Holsbeke C., Van Belle V., Leone F.D. et al. Prospective external validation of the ‘ovarian crescent sign’ as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology. Ultrasound Obstet. Gynecol. 2010; 36: 81–87. http://doi.org/10.1002/uog.7625</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Чекалова М.А. Ультразвуковая диагностика в онкогинекологии. Онкогинекология: Национальное руководство / Под ред. Каприна А.Д. М.: ГЭОТАР-медиа, 2019: 51–76.</mixed-citation><mixed-citation xml:lang="en">Chekalova M.A. Ultrasound diagnostics in oncogynecology. Oncogynecology. The National Guide / Ed. Kaprin A.D. Moscow: GEOTAR-media, 2019: 51–76. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Shepherd J.H. Revised FIGO staging for gynaecological cancer. Br. J. Obstet. Gynaecol. 1989; 96: 889–892. http://doi.org/10.1111/j.1471-0528.1989.tb03341.x</mixed-citation><mixed-citation xml:lang="en">Shepherd J.H. Revised FIGO staging for gynaecological cancer. Br. J. Obstet. Gynaecol. 1989; 96: 889–892. http://doi.org/10.1111/j.1471-0528.1989.tb03341.x</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Fruscella E., Testa A.C., Ferrandina G. et al. Ultrasound features of different histopathological subtypes of borderline ovarian tumors. Ultrasound Obstet. Gynecol. 2005; 26: 644–650. http://doi.org/10.1002/uog.2607</mixed-citation><mixed-citation xml:lang="en">Fruscella E., Testa A.C., Ferrandina G. et al. Ultrasound features of different histopathological subtypes of borderline ovarian tumors. Ultrasound Obstet. Gynecol. 2005; 26: 644–650. http://doi.org/10.1002/uog.2607</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Fagotti A., Ludovisi M., De Blasis I. et al. The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. Hum. Reprod. 2012; 27 (9):2676–2683. http://doi.org/10.1093/humrep/des231</mixed-citation><mixed-citation xml:lang="en">Fagotti A., Ludovisi M., De Blasis I. et al. The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. Hum. Reprod. 2012; 27 (9):2676–2683. http://doi.org/10.1093/humrep/des231</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Bruno M., Capanna G., Stanislao V. et al. Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center. Diagnostics (Basel). 2023; 13 (20): 3247. http://doi.org/10.3390/diagnostics13203247</mixed-citation><mixed-citation xml:lang="en">Bruno M., Capanna G., Stanislao V. et al. Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center. Diagnostics (Basel). 2023; 13 (20): 3247. http://doi.org/10.3390/diagnostics13203247</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Gadducci A., Cosio S. Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research. Cancers (Basel). 2020; 12 (5): 1336. http://doi.org/10.3390/cancers12051336</mixed-citation><mixed-citation xml:lang="en">Gadducci A., Cosio S. Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research. Cancers (Basel). 2020; 12 (5): 1336. http://doi.org/10.3390/cancers12051336</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Fischerova D., Smet C., Scovazzi U. et al. Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements. Int. J. Gynecol. Cancer. 2024; 34 (3): 363–378. http://doi.org/10.1136/ijgc-2023-004609</mixed-citation><mixed-citation xml:lang="en">Fischerova D., Smet C., Scovazzi U. et al. Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements. Int. J. Gynecol. Cancer. 2024; 34 (3): 363–378. http://doi.org/10.1136/ijgc-2023-004609</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Borges A.L., Brito M., Ambrósio P. et al. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study. Ultrasound Obstet. Gynecol. 2024; 64 (4): 538–549. http://doi.org/10.1002/uog.27641</mixed-citation><mixed-citation xml:lang="en">Borges A.L., Brito M., Ambrósio P. et al. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study. Ultrasound Obstet. Gynecol. 2024; 64 (4): 538–549. http://doi.org/10.1002/uog.27641</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
